Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium
2024 · Blood Advances · 8 citations
https://doi.org/10.1182/bloodadvances.2024014674
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
87
Citations
6
h-index
5
i10-index
Mark N Sorial is an academic researcher from Massachusetts General Hospital. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Chronic Lymphocytic Leukemia Research & CAR-T cell therapy research. The author has an h-index of 6, co-authored 19 publications.
ORCID: 0000-0002-6906-0568Click to start Chat